Board of Directors

Board of Directors

Gisela Sitbon

Born 1958
Board member since 2012, Chairman since 2014

Chairman of the board, chairman of the remuneration committee

Education and training:

PhD in Medical Sciences from the Karolinska Institute in Solna

Main experience:

Gisela Sitbon has over 25 years of experience from the life science industry, of which more than ten years in senior positions (including CEO) at Professional Genetics Laboratory AB and five years as section manager at Karo Bio AB.

Other appointments:

Active as business coach within the life science sector. Chairman of the board of Gradientech AB, Emplicure AB, Amplicon AB and Emplipharm AB. Board member of Uppsala Universitet Invest AB,  Annexin Pharmaceuticals AB, Encare AB and Sitbon Bioscience Partner Zenz AB.

Holdings:

Holds 26,666 shares through the company Sitbon Bioscience Partner Zenz AB.

Independent in relation to company and company management: Yes

Independent in relation to primary owners: Yes

Mattias Bengtsson

Born 1969
Board member since 2019
Member of the remuneration committee

EDUCATION AND TRAINING:

Master of Science in Chemical Engineering at Chalmers University of Technology in Gothenburg,  MBA at University of Gothenburg School of Business

MAIN EXPERIENCE:

Mattias Bengtsson has more than 20 years of experience from the chemical and life science industry. He has held senior positions within AkzoNobel, more specifically in industrial purification of pharmaceuticals, for example as General Manager Kromasil and Fine Chemicals, Global Sales and Marketing Manager, Manufacturing Manager and Product Category Manager. In addition, Mattias has held several positions in process chemistry at AstraZeneca in Södertälje.

OTHER APPOINTMENTS:

Business Unit Manager BioMedical & Research, AddLife AB. Chairman of the board of Bergman Labora AB, LabRobot Products AB and Bioline Scientific AB. Board member of BioNordika (Sweden) AB, MaBeRo Consulting AB, LabVent Control AS, Holm&Halby AS and EuroClone Spa.

Holdings:

Holds 13,000 shares.

Independent in relation to company and company management: No

Independent in relation to primary owners: Yes

Thomas Eldered

Born 1960
Board member since 2021
Member of the audit committee

Education and training:

Master of Science in Industrial Economics, Linköpings tekniska högskola

Main experience:

Thomas Eldered is co-founder of Recipharm AB where he also worked as CEO between 2008–2021. Prior to that, Thomas was Vice President of Recip AB and Factory Manager for Pharmacia. Thomas has also held various assignments as chairman of the board, board member or deputy board member in companies primarily in the life science sector.                                                                               

Other appointments:

Chairman of Flerie Invest AB, Amarna Therapeutics BV, Prokarium Ltd and North X Biologics AB. Board member of Chromafora AB, Bohus Biotech AB, Buzzard Pharmaceuticals AB, Sixera Pharma AB, Kahr Medical Ltd, Flerie Förvaltning AB, Cordinvest AB, Pingvinen Penningplacering AB, Xintela AB (publ), Toleranzia AB (publ), Flerie Participation AB.

Holdings:

Holds 14,901,635 shares through Flerie Invest AB.

Independent in relation to company and company management: Yes

Independent in relation to primary owners: No

Anders Rabbe, Board Member Nanologica AB

Anders Rabbe

Born 1970
Board member since 2020
Member of the audit committee

Education and training:

Bachelor of Economics in Business Administration from Webster University, Genève. 

Main experience:

Anders Rabbe has been the CEO of several companies in the biotechnology and financial sector, including Isofol Medical (publ) and WntResearch AB (publ).

Other appointments:

CEO of Mindforce Game Lab AB. Board member and partner in Investmentaktieboalget Akkumula, Albonja AB and Epicyt Pharma AB, and deputy board member of Malira AB.

Holdings:

Holds 13,333 shares.

Independent in relation to company and company management: Yes

Independent in relation to primary owners: Yes

Lena Torlegård, Board Member Nanologica AB

Lena Torlegård

Born 1963
Board member since 2014
Chairman of the audit committee

EDUCATION AND TRAINING:

Bachelor of Science in Business Administration from the Stockholm School of Economics

MAIN EXPERIENCE:

Lena Torlegård has over 20 years of experience as a communications consultant for a large number of companies, including companies in the life science industry. Lena works through Lena Torlegård AB as an independent advisor in financial and corporate communication with several customers in the life science sector.

OTHER APPOINTMENTS:

Communications consultant at Lena Torlegård AB. Chairman of the board of CoDesignSweden AB and board member of Lena Torlegård AB.

Holdings:

Holds 7,652 shares.

Independent in relation to company and company management: Yes

Independent in relation to primary owners: Yes